Jason Ye, MD

Associate Professor of Clinical Radiation Oncology

Director of Clinical Operations, Department of Radiation Oncology at Norris Cancer Hospital

Image of Jason Ye, MD
Is this your profile? Click to edit

Overview

Dr. Jason Ye is an Associate Professor of Clinical Radiation Oncology at Keck School of Medicine of USC and serves as the Director of Clinical Operations of Radiation Oncology at USC Norris Comprehensive Cancer. He joined USC in August 2016. Dr. Ye completed a seven-year accelerated liberal arts/medical (BA/MD) education from Boston University. He completed his medical doctorate degree, graduating cum laude and was also inducted into the Alpha Omega Alpha Honor Medical Society. He completed his residency in Radiation Oncology at Weill Cornell Medicine – New York Presbyterian Hospital, where he also served as Chief Resident.

Dr. Ye has presented and published studies on topics regarding breast, lung, and central nervous system cancers.  He continues to lead various research and education efforts on these and other topics at USC and collaborates with experts around the U.S. and the world. In addition, Dr. Ye aims to enhance the education of practicing providers and improve the standard of care by actively participating within various national organizations such as the American Society for Radiation Oncology (ASTRO), American Board of Radiology (ABR), American Radium Society (ARS) etc.

Dr. Ye specializes in various advanced radiation treatment techniques, such as stereotactic body radiotherapy (SBRT), biology guided radiation therapy (BGRT) intensity modulated radiation therapy (IMRT), prone breast radiotherapy, surface guided radiation therapy (SGRT) as well as stereotactic radiosurgery (SRS) including the use of Gamma Knife. His expertise in these advanced treatments allows for safe and effective curative treatments in early-stage disease, as well as definitive treatments for oligometastatic/oligoprogressive disease in late-stage disease.

Clinical Expertise: Breast, Lung, CNS tumors, Radiosurgery

Languages Spoken: English, Chinese, and Japanese

Publications

  • Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non-small cell lung cancer with positive surgical margins. JTCVS Open. 2023 Jun; 14:472-482.. View in PubMed
  • Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer. Nutrients. 2023 Jan 09; 15(2).. View in PubMed
  • Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma. Sci Rep. 2022 Nov 04; 12(1):18731.. View in PubMed
  • Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients. Ann Surg Oncol. 2023 Feb; 30(2):1017-1025.. View in PubMed
  • Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma. Sci Rep. 2022 Sep 02; 12(1):15013.. View in PubMed
  • The abscopal effect: systematic review in patients with brain and spine metastases. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac132.. View in PubMed
  • Making the Right Choice: Radiate Only What’s Left, the Rest is Left. Int J Radiat Oncol Biol Phys. 2022 Jul 01; 113(3):491.. View in PubMed
  • Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non-small Cell Lung Cancer. Am J Clin Oncol. 2022 04 01; 45(4):146-154.. View in PubMed
  • Pilot Study Demonstrating the Value of Interdisciplinary Education on the Integration of Radiation Therapy in Lung Cancer Management. J Cancer Educ. 2023 04; 38(2):590-595.. View in PubMed
  • Automatic differentiation of Grade I and II meningiomas on magnetic resonance image using an asymmetric convolutional neural network. Sci Rep. 2022 03 09; 12(1):3806.. View in PubMed